1. Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004, 4:579-591.
2. Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB: Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121:1356-1364.
3. Vos MB, Kaar JL, Welsh JA, Van Horn LV, Feig DI, Anderson CAM, Patel MJ, Cruz Munos J, Krebs NF, Xanthakos SA, Johnson RK: Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association. Circulation 2017, 135:e1017-e1034.
4. Rother KI, Conway EM, Sylvetsky AC: How Non-nutritive Sweeteners Influence Hormones and Health. Trends Endocrinol Metab 2018, 29:455-467.
5. Johnson RK, Lichtenstein AH, Anderson CAM, Carson JA, Després JP, Hu FB, Kris-Etherton PM, Otten JJ, Towfighi A, Wylie-Rosett J: Low-Calorie Sweetened Beverages and Cardiometabolic Health: A Science Advisory From the American Heart Association. Circulation 2018, 138:e126-e140.
6. Imamura F, O'Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, Forouhi NG: Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. Bmj 2015, 351:h3576.
7. Swithers SE: Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab 2013, 24:431-441.
8. Gardener H, Elkind MSV: Artificial Sweeteners, Real Risks. Stroke 2019, 50:549-551.
9. Greenhill C: Gut microbiota: not so sweet--artificial sweeteners can cause glucose intolerance by affecting the gut microbiota. Nature reviews Endocrinology 2014, 10:637.
10. Valdes AM, Walter J, Segal E, Spector TD: Role of the gut microbiota in nutrition and health. Bmj 2018, 361:k2179.
11. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, et al: Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014, 514:181-186.
12. Abou-Donia MB, El-Masry EM, Abdel-Rahman AA, McLendon RE, Schiffman SS: Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J Toxicol Environ Health A 2008, 71:1415-1429.
13. Palmnäs MSA, Cowan TE, Bomhof MR, Su J, Reimer RA, Vogel HJ, Hittel DS, Shearer J: Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PloS one 2014, 9:e109841.
14. AlDeeb OA, Mahgoub H, Foda NH: Sucralose. Profiles Drug Subst Excip Relat Methodol 2013, 38:423-462.
15. Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL, Horowitz M, Rayner CK: Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2009, 296:G735-739.
16. Mezitis NH, Maggio CA, Koch P, Quddoos A, Allison DB, Pi-Sunyer FX: Glycemic effect of a single high oral dose of the novel sweetener sucralose in patients with diabetes. Diabetes Care 1996, 19:1004-1005.
17. Wang QP, Browman D, Herzog H, Neely GG: Non-nutritive sweeteners possess a bacteriostatic effect and alter gut microbiota in mice. PLoS One 2018, 13:e0199080.
18. Qian C, Qi Y, Feng R, Yang M, Zhang M, Liu W, Rayner CK, Ma J: Sucralose can improve glucose tolerance and upregulate expression of sweet taste receptors and glucose transporters in an obese rat model. Eur J Nutr 2020.
19. Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. Faseb j 2008, 22:659-661.
20. Zhang M, Feng R, Yang M, Qian C, Wang Z, Liu W, Ma J: Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats. BMJ Open Diabetes Res Care 2019, 7:e000717.
21. Tremaroli V, Bäckhed F: Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249.
22. Chi L, Bian X, Gao B, Tu P, Lai Y, Ru H, Lu K: Effects of the Artificial Sweetener Neotame on the Gut Microbiome and Fecal Metabolites in Mice. Molecules (Basel, Switzerland) 2018, 23.
23. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
24. Thomson P, Santibanez R, Aguirre C, Galgani JE, Garrido D: Short-term impact of sucralose consumption on the metabolic response and gut microbiome of healthy adults. Br J Nutr 2019, 122:856-862.
25. Uebanso T, Ohnishi A, Kitayama R, Yoshimoto A, Nakahashi M, Shimohata T, Mawatari K, Takahashi A: Effects of Low-Dose Non-Caloric Sweetener Consumption on Gut Microbiota in Mice. Nutrients 2017, 9.
26. Dalenberg JR, Patel BP, Denis R, Veldhuizen MG, Nakamura Y, Vinke PC, Luquet S, Small DM: Short-Term Consumption of Sucralose with, but Not without, Carbohydrate Impairs Neural and Metabolic Sensitivity to Sugar in Humans. Cell Metab 2020, 31:493-502.e497.
27. Rodriguez-Palacios A, Harding A, Menghini P, Himmelman C, Retuerto M, Nickerson KP, Lam M, Croniger CM, McLean MH, Durum SK, et al: The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis. Inflammatory bowel diseases 2018, 24:1005-1020.
28. Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A: Proteobacteria: A Common Factor in Human Diseases. Biomed Res Int 2017, 2017:9351507.
29. Bian X, Chi L, Gao B, Tu P, Ru H, Lu K: The artificial sweetener acesulfame potassium affects the gut microbiome and body weight gain in CD-1 mice. PLoS One 2017, 12:e0178426.
30. Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, et al: Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med 2019, 25:1096-1103.
31. Bian X, Chi L, Gao B, Tu P, Ru H, Lu K: Gut Microbiome Response to Sucralose and Its Potential Role in Inducing Liver Inflammation in Mice. Front Physiol 2017, 8:487.
32. Lecomte V, Kaakoush NO, Maloney CA, Raipuria M, Huinao KD, Mitchell HM, Morris MJ: Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS One 2015, 10:e0126931.
33. Wu F, Guo X, Zhang J, Zhang M, Ou Z, Peng Y: Phascolarctobacterium faecium abundant colonization in human gastrointestinal tract. Exp Ther Med 2017, 14:3122-3126.
34. Canfora EE, Meex RCR, Venema K, Blaak EE: Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol 2019, 15:261-273.